Who owns ACORDA THERAPEUTICS INC?
- Ticker: ACOR
- CUSIP Number: 00484m700
Tip: Access positions for across all investors
Analyze quarterly positions in Acorda Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acorda Therapeutics stock
Who bought or sold ACORDA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Davidson Kempner Capital Management | 55k | $801k | 0% | Dec 2023 |
|
| Vanguard Group | 11k | $163k | 1% | Dec 2023 |
|
| Wells Fargo & Company | 3.7k | $57k | 0% | Dec 2023 |
|
| Russell Investments | 300.00 | $4.4k | 0% | Dec 2023 |
|
| UBS Group | 298.00 | $4.5k | 122% | Dec 2023 |
|
| Bank of America Corporation | 50.00 | $754.000000 | 100% | Dec 2023 |
|
| Royal Bank of Canada | 14.00 | $0 | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 3.00 | $44.000100 | 50% | Dec 2023 |
|
| Advisor Group Holdings | 1.00 | $15.000000 | -50% | Dec 2023 |
|
Who sold out of Acorda Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Deutsche Bank Aktiengesellschaft | Sep 2023 | 1.7k | $26k |